EUVIMEDEUVIMED entdecken
Open Access

Evaluation of N 6 -methyldeoxyadenosine antibody-based genomic profiling in eukaryotes

Brian M Debo, Benjamin J Mallory, Andrew B Stergachis iD

Genome Research · 2023

DOI: 10.1101/gr.276696.122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genome Research, 2023. Verfasst von Brian M Debo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. Hauptthemen laut MEDLINE: Eukaryota, Drosophila melanogaster. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low-level DNA N 6 -methyldeoxyadenosine (DNA-m6A) has recently been reported across various eukaryotes. Although anti-m6A antibody–based approaches are commonly used to measure DNA-m6A levels, this approach is known to be confounded by DNA secondary structures, RNA contamination, and bacterial contamination. To evaluate for these confounding features, we introduce an approach for systematically validating the selectivity of antibody-based DNA-m6A methods and use a highly selective anti-DNA-m6A antibody to reexamine patterns of DNA-m6A in C. reinhardtii , A. thaliana , and D. melanogaster . Our findings raise caution about the use of antibody-based methods for endogenous m6A quantification and mapping in eukaryotes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EukaryotaDrosophila melanogasterAnimalsRNAAntibodiesDNAGenomics

Substanzen

RNAAntibodiesDNA

Autor:innen und Institutionen

  • Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Department of Genome Sciences, University of Washington, Seattle, Washington 98195, USA.
  • Department of Genome Sciences, University of Washington, Seattle, Washington 98195, USA; absterga@uw.edu.
  • Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington 98195-7720, USA.
  • Brotman Baty Institute for Precision Medicine, Seattle, Washington 98195, USA.

ORCID-Profile: Andrew B Stergachis

Förderung

  • NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • National Institute of General Medical Sciences
  • Burroughs Wellcome Fund

Zitieren

APA

Debo, B. M., Mallory, B. J., & Stergachis, A. B. (2023). Evaluation of N 6 -methyldeoxyadenosine antibody-based genomic profiling in eukaryotes. Genome Research. https://doi.org/10.1101/gr.276696.122

Vancouver

Debo BM, Mallory BJ, Stergachis AB. Evaluation of N 6 -methyldeoxyadenosine antibody-based genomic profiling in eukaryotes. Genome Research. 2023. doi:10.1101/gr.276696.122

BibTeX
@article{Debo2023,
  author = {Debo, Brian M and Mallory, Benjamin J and Stergachis, Andrew B},
  title = {Evaluation of N 6 -methyldeoxyadenosine antibody-based genomic profiling in eukaryotes},
  journal = {Genome Research},
  year = {2023},
  doi = {10.1101/gr.276696.122}
}
Kostenlos starten →